z-logo
open-access-imgOpen Access
Implementation of a point mutation assay for HIV drug resistance testing in Kenya
Author(s) -
Horacio A. Duarte,
Ingrid Beck,
Molly Levine,
Catherine Kiptinness,
James M. Kingoo,
Bhavna Chohan,
Samah R. Sakr,
Michael H. Chung,
Lisa M. Frenkel
Publication year - 2018
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000001934
Subject(s) - kenya , medicine , drug resistance , hiv drug resistance , human immunodeficiency virus (hiv) , viral load , family medicine , antiretroviral therapy , biology , microbiology and biotechnology , ecology
An increasing prevalence of HIV pretreatment drug resistance (PDR) has been observed in Africa, which could decrease the effectiveness of antiretroviral therapy (ART) programs. We describe our experiences, the costs and challenges of implementing an oligonucleotide ligation assay (OLA) for management of PDR in Nairobi, Kenya.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here